25D-NM-NDEAOP
| Clinical data | |
|---|---|
| Other names | 25D-NM-NDECE; 25D-NM-NDEPA; N-Methyl-N-(3-diethylamino-3-oxopropyl)-2,5-dimethoxy-4-methylphenethylamine; N-Methyl-N-(3-diethylamino-3-oxopropyl)-2C-D; N-Methyl-N-(2-diethylcarbamoylethyl)-2,5-dimethoxy-4-methylphenethylamine; N-Methyl-N-(2-diethylcarbamoylethyl)-2C-D; NM-NDEAOP-2C-D; NM-NDECE-2C-D; "Compound 4" |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H32N2O3 |
| Molar mass | 336.476 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
25D-NM-NDEAOP, or 25D-NM-NDEPA, is a chemical compound of the phenethylamine and 2C families. It is a simplified or partial lysergamide and is a derivative of 2C-D with a lysergic acid diethylamide (LSD)-like N-(3-diethylamino-3-oxopropyl)- substitution.